Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pediatrics

What Are Common SPCD Misdiagnoses?

At a Glance

Systemic Primary Carnitine Deficiency (SPCD) is a rare disorder that prevents the body from using fat for energy. Because symptoms vary by age, it is commonly misdiagnosed as Reye syndrome in infants, viral myocarditis in children, and chronic fatigue syndrome or cardiomyopathy in adults.

Because Systemic Primary Carnitine Deficiency (SPCD) is extremely rare and presents with symptoms that overlap with many common illnesses, it is frequently misdiagnosed before the correct metabolic issue is identified [1][2]. SPCD prevents the body from using fat for energy, which starves the heart, liver, and muscles [3][4]. Depending on a person’s age, this energy crisis can mimic different conditions—often acting as a “red herring” that leads doctors down the wrong diagnostic path [5].

Common Misdiagnoses by Age Group

Infants: Reye-Like Syndrome and Viral Hepatitis

In infancy, SPCD often presents as a severe metabolic crisis triggered by fasting or a common illness [6].

  • Reye-like syndrome: Infants may develop severe lethargy, liver dysfunction, and hypoglycemia (dangerously low blood sugar) [6][5]. Because the symptoms look identical to Reye syndrome—a rare condition causing liver and brain swelling—SPCD is often mistaken for it [7].
  • Viral hepatitis: When SPCD causes liver distress and elevated liver enzymes, doctors might suspect a viral liver infection (hepatitis) before considering a rare metabolic disorder [5][8].

Children: Viral Myocarditis and Muscular Dystrophy

As children grow, SPCD tends to affect the heart and skeletal muscles, which rely heavily on fat for energy.

  • Viral myocarditis: A child with SPCD may suddenly develop an enlarged, weakened heart, leading to respiratory distress and severe fatigue [9][10]. Doctors frequently mistake this for viral myocarditis (inflammation of the heart muscle caused by a virus) [2].
  • Muscular dystrophy: Children may experience significant muscle weakness, especially in the hips and shoulders, along with muscle breakdown [11][9]. Because this mirrors primary muscle diseases, they are sometimes misdiagnosed with muscular dystrophy [12].

Adults: Idiopathic Cardiomyopathy and Chronic Fatigue Syndrome

Adults who went undiagnosed in childhood often have milder or more chronic symptoms, enduring years of unexplained health issues.

  • Idiopathic cardiomyopathy: Adults may develop a weakened, enlarged heart with no obvious cause, leading to a diagnosis of idiopathic (unexplained) cardiomyopathy [3][4]. Unlike SPCD, idiopathic cardiomyopathy is usually a diagnosis of exclusion that does not respond to metabolic treatments [13].
  • Chronic Fatigue Syndrome (ME/CFS): Because adults with SPCD can experience profound, debilitating exhaustion and muscle weakness without obvious organ failure, their symptoms significantly overlap with chronic fatigue syndrome [14][15].
  • Maternal Incidental Diagnosis: Many asymptomatic adult women only discover they have SPCD because their baby’s newborn screen flags for low carnitine, which was actually passed down from the mother’s undetected deficiency [16][17].

How Specialized Testing Solves the Mystery

To tell SPCD apart from these “red herring” diagnoses, doctors must look for the underlying inability to transport carnitine. Standard routine blood panels (like a CBC or CMP) will not catch this, so specific, specialized testing is required:

  • Newborn Screening (NBS): In many countries, SPCD is now included in standard newborn screening panels using tandem mass spectrometry [16][18]. This test detects low free carnitine levels shortly after birth, often catching the disease before any symptoms or misdiagnoses occur [19].
  • Plasma Free Carnitine Levels: If SPCD is suspected later in life, a specific blood test to measure free carnitine (C0) is the most crucial step. In SPCD, plasma carnitine levels are extremely low, which immediately distinguishes it from conditions like viral myocarditis, muscular dystrophy, or chronic fatigue syndrome where carnitine levels are normal [1][20][3].
  • Metabolic Profiling (Acylcarnitine Profile): During a crisis, infants with SPCD will have low blood sugar without producing ketones (hypoketotic hypoglycemia) [6][21]. Ketones are the chemical byproduct of the body burning fat for energy; their absence proves the body cannot use its fat stores. Standard liver diseases or Reye syndrome show different metabolic signatures.
  • Genetic Testing: The gold standard for confirming an SPCD diagnosis is checking for mutations in the SLC22A5 gene [5][22]. This definitively rules out other genetic conditions like muscular dystrophy, which are caused by entirely different genes [1][23].

Because SPCD is highly treatable with lifelong, high-dose prescription L-carnitine therapy under medical supervision—which can dramatically improve or even reverse heart failure and muscle weakness—getting the correct diagnosis is life-saving [2][11][3].

Common questions in this guide

What is SPCD commonly misdiagnosed as in children and infants?
In infants, SPCD causes liver distress and dangerously low blood sugar, which strongly resembles Reye syndrome or viral hepatitis. In children, the severe heart and muscle weakness it causes are frequently mistaken for viral myocarditis or muscular dystrophy.
Can adults be misdiagnosed with Systemic Primary Carnitine Deficiency?
Adults with undiagnosed SPCD often experience chronic exhaustion and muscle weakness without obvious organ failure. Because of these symptoms, they are frequently misdiagnosed with chronic fatigue syndrome (ME/CFS) or idiopathic cardiomyopathy.
What specific tests are needed to diagnose SPCD?
Standard routine blood panels, like a CBC or CMP, cannot detect SPCD. Doctors must order specialized tests such as plasma free carnitine levels, an acylcarnitine profile, or genetic testing for the SLC22A5 gene to confirm the diagnosis.
What does it mean if my baby's newborn screen shows low carnitine?
A low carnitine result on a newborn screen could mean your baby has SPCD. However, it can also happen if the mother has an undetected, asymptomatic carnitine deficiency that was passed down. Additional specialized testing for both mother and baby is required to find the exact cause.
Is Systemic Primary Carnitine Deficiency treatable once correctly diagnosed?
SPCD is highly treatable with lifelong, high-dose prescription L-carnitine therapy. When managed under close medical supervision, this treatment can dramatically improve or even reverse the heart failure and severe muscle weakness associated with the condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my symptoms, would it be appropriate to check my plasma free and total carnitine levels to rule out a metabolic issue?
  2. 2.Has a genetic panel been considered to look for mutations in the SLC22A5 gene or other treatable metabolic conditions?
  3. 3.If my heart or muscle issues are currently labeled 'idiopathic,' what specific tests have we done to ensure we aren't missing a metabolic cause?
  4. 4.During previous episodes of illness or fatigue, did my blood work show low blood sugar without ketones?
  5. 5.If my newborn screening results showed low carnitine, what are our next steps to distinguish between an infant deficiency and a maternal deficiency?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Molecular investigation in Chinese patients with primary carnitine deficiency.

    Zhang Y, Li H, Liu J, et al.

    Molecular genetics & genomic medicine 2019; (7(9)):e901 doi:10.1002/mgg3.901.

    PMID: 31364285
  2. 2

    Primary carnitine deficiency - diagnosis after heart transplantation: better late than never!

    Grünert SC, Tucci S, Schumann A, et al.

    Orphanet journal of rare diseases 2020; (15(1)):87 doi:10.1186/s13023-020-01371-2.

    PMID: 32276632
  3. 3

    Primary carnitine deficiency in two sisters with intractable epilepsy and reversible metabolic cardiomyopathy: Two case reports.

    Yang XF, Liu GS, Yi B

    Experimental and therapeutic medicine 2020; (20(5)):118 doi:10.3892/etm.2020.9246.

    PMID: 33005244
  4. 4

    Primary Carnitine Deficiency and Newborn Screening for Disorders of the Carnitine Cycle.

    Longo N

    Annals of nutrition & metabolism 2016; (68 Suppl 3()):5-9 doi:10.1159/000448321.

    PMID: 27931018
  5. 5

    Primary carnitine deficiency with severe acute hepatitis following rotavirus gastroenteritis.

    Ishige M, Fuchigami T, Furukawa M, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019; (25(11)):913-916 doi:10.1016/j.jiac.2019.04.020.

    PMID: 31189503
  6. 6

    Systemic primary carnitine deficiency with hypoglycemic encephalopathy.

    Jun JS, Lee EJ, Park HD, Kim HS

    Annals of pediatric endocrinology & metabolism 2016; (21(4)):226-229 doi:10.6065/apem.2016.21.4.226.

    PMID: 28164076
  7. 7

    A Rare Case Report of Hypoketotic Hypoglycemia Induced Seizures Due to Secondary Carnitine Deficiency in a 44-year-old Female.

    Bangolo A, Tesoro N, Onyeka S, et al.

    Journal of community hospital internal medicine perspectives 2024; (14(3)):68-71 doi:10.55729/2000-9666.1279.

    PMID: 39036584
  8. 8

    The role of genetic defects in carnitine-associated hepatic encephalopathy: a review of literature.

    Kheirandish A, Shah Hosseini R, Yaghoobpoor S, et al.

    Gastroenterology and hepatology from bed to bench 2024; (17(4)):357-378 doi:10.22037/ghfbb.v17i4.2960.

    PMID: 40406429
  9. 9

    A case of atypical systemic primary carnitine deficiency in Saudi Arabia.

    Alghamdi A, Almalki H, Shawli A, et al.

    Pediatric reports 2018; (10(2)):7705 doi:10.4081/pr.2018.7705.

    PMID: 30069296
  10. 10

    A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features.

    Jolfayi AG, Naderi N, Ghasemi S, et al.

    BMC cardiovascular disorders 2024; (24(1)):1 doi:10.1186/s12872-023-03676-z.

    PMID: 38166572
  11. 11

    Primary carnitine deficiency in a 57-year-old patient with recurrent exertional rhabdomyolysis.

    Echaniz-Laguna A, Biancalana V, Gaignard P, Chanson JB

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-224272.

    PMID: 29895548
  12. 12

    Metabolic lipid muscle disorders: biomarkers and treatment.

    Angelini C, Pennisi E, Missaglia S, Tavian D

    Therapeutic advances in neurological disorders 2019; (12()):1756286419843359 doi:10.1177/1756286419843359.

    PMID: 31040882
  13. 13

    Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study.

    Ware SM, Wilkinson JD, Tariq M, et al.

    Journal of the American Heart Association 2021; (10(9)):e017731 doi:10.1161/JAHA.120.017731.

    PMID: 33906374
  14. 14

    CDC Grand Rounds: Chronic Fatigue Syndrome - Advancing Research and Clinical Education.

    Unger ER, Lin JS, Brimmer DJ, et al.

    MMWR. Morbidity and mortality weekly report 2016; (65(50-51)):1434-1438 doi:10.15585/mmwr.mm655051a4.

    PMID: 28033311
  15. 15

    Understanding neuromuscular disorders in chronic fatigue syndrome.

    Jammes Y, Retornaz F

    F1000Research 2019; (8()) doi:10.12688/f1000research.18660.1.

    PMID: 31814961
  16. 16

    Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China.

    Chang S, Yang Y, Xu F, et al.

    Frontiers in genetics 2022; (13()):1062715 doi:10.3389/fgene.2022.1062715.

    PMID: 36568374
  17. 17

    A newborn with seizures born to a mother diagnosed with primary carnitine deficiency.

    Chen S, Hu Y, Huang Y, et al.

    BMC pediatrics 2019; (19(1)):79 doi:10.1186/s12887-019-1452-4.

    PMID: 30885166
  18. 18

    Benefits and pitfalls in newborn screening for carnitine uptake deficiency: a 4-year single-center experience.

    Turturo M, Rossi A, Barretta F, et al.

    Orphanet journal of rare diseases 2025; (21(1)).

    PMID: 41310792
  19. 19

    Incorporating Next-Generation Sequencing as a Second-Tier Test for Primary Carnitine Deficiency.

    Lin Y, Zheng Z, Lin W, Peng W

    Molecular genetics & genomic medicine 2024; (12(9)):e70003 doi:10.1002/mgg3.70003.

    PMID: 39248612
  20. 20

    Analysis of genetic mutation distribution and metabolic characteristics in patients with primary carnitine deficiency from the Ganzhou area, China.

    Tu X, Zhang F, Chen J, Xie C

    Clinica chimica acta; international journal of clinical chemistry 2026; (584()):120873 doi:10.1016/j.cca.2026.120873.

    PMID: 41620002
  21. 21

    Beta-ketothiolase deficiency: A case with unusual presentation of nonketotic hypoglycemic episodes due to coexistent probable secondary carnitine deficiency.

    Alijanpour M, Sasai H, Abdelkreem E, et al.

    JIMD reports 2019; (46(1)):23-27 doi:10.1002/jmd2.12022.

    PMID: 31240151
  22. 22

    Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome.

    Gélinas R, Leach E, Horvath G, Laksman Z

    The Canadian journal of cardiology 2019; (35(9)):1256.e1-1256.e2 doi:10.1016/j.cjca.2019.05.014.

    PMID: 31472821
  23. 23

    Clinical, Biochemical and Molecular Characterisation of Newborns With Fatty Acid β-Oxidation Disorders: Novel Variants in the ACADM , ACADVL and SLC22A5 Genes.

    Hidalgo Mayoral I, Herranz Cecilia A, Rodríguez-Jiménez C, et al.

    Clinical genetics 2026; (109(4)):742-746 doi:10.1111/cge.70083.

    PMID: 41022664

This page provides informational content about the misdiagnosis of Systemic Primary Carnitine Deficiency (SPCD). It does not replace professional medical evaluation, so please consult your doctor if you suspect an underlying metabolic disorder.

Get notified when new evidence is published on Systemic primary carnitine deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.